NLRP3 and drug-induced dyskinesia: Microglial NLRP3 inflammasome activation induces dopaminergic neuron death and subsequent dyskinesia in PD, while dopamine can significantly reduce NLRP3-dependent inflammasome activation in mixed glial cells stimulated by NLRP3 agonists.